Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Diamond Wipes International, Inc.
WARNING LETTER
•Diamond Wipes International, Inc.•May 17, 2017

Diamond Wipes International, Inc. – FDA Warning Letter, May 17, 2017

Record Details

The FDA inspected Diamond Wipes International Inc. from May 8-17, 2017, identifying significant Current Good Manufacturing Practice (CGMP) violations that render their finished drug products adulterated under 21 U.S.C. 351(a)(2)(B). Key deficiencies include the firm's failure to establish adequate production and process controls (21 CFR 211.100(a)), specifically concerning a non-validated water system that consistently produced microbiologically contaminated water, including potentially pathogenic gram-negative bacteria, used in topical drug products. The firm also failed to thoroughly investigate unexplained discrepancies or out-of-specification (OOS) results (21 CFR 211.192), releasing products with fungal levels exceeding specifications without proper investigation. Furthermore, a repeat observation highlighted the firm's failure to establish an adequate quality control unit (21 CFR 211.22(a)) with the authority to approve products before distribution, as lots were released prior to complete analytical testing and QCU approval. The FDA recommended engaging a CGMP consultant and noted the firm's role as a contract manufacturer, emphasizing their responsibility for compliance and informing clients of quality issues. The letter requires comprehensive corrective and preventive actions, including water system remediation, OOS investigation improvements, QCU strengthening, and a risk assessment of distributed products, with a 15-working-day response. Failure to comply may result in legal action, including seizure, injunction, and impact on drug application approvals and export certificates.

Company
Diamond Wipes International, Inc.
Inspection date
May 17, 2017
Product type
Drugs
Office
Los Angeles District Office
People
  • David Mazzera (Chief. Environmental Program Manager I)
  • Steven E. Porter (Program Division Director)
View Company Profile

ID · 56b991ce-9de7-4319-84e5-24f1fb7a89f0

Violation Codes8
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.100(a)21 CFR 211.19221 CFR 211.22(a)21 CFR 211.34FD&C Act 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Diamond Wipes International, Inc.
  • 483 - 2025-10-17October 17, 2025
  • 483 - 2021-03-19March 19, 2021
  • 483 - 2019-09-06September 6, 2019
  • 483 - 2019-04-19April 19, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Diamond Wipes International, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.